Organisational and personnel changes at Hirslanden Lausanne

In his new role as Head of Radiology Development, Cédric Bossart (48) will be responsible for the structuring of the framework conditions for the radiology division throughout Switzerland on a strategic and operational level. He will take on his new role on 01 April 2021. With the creation of this position, Hirslanden will strengthen radiology as an independent business unit and take a further step towards becoming an integrated healthcare provider. Jean-Claude Chatelain, Hospital Manager of Clinique Cecil, will manage both Hirslanden hospitals in Lausanne from the beginning of April until the end of August and will then be available to Inka Moritz and the West Region in an advisory capacity. He will retire on 31 March 2022.

Under the leadership of the two Hospital Managers Bossart and Chatelain, the Clinique Bois-Cerf and the Clinique Cecil have further established themselves as first-class medical care centres. "The Executive Committee thanks Cédric Bossart and Jean-Claude Chatelain for their many years of successful work as managers of the Hirslanden hospitals in Lausanne. Both have significantly and sustainably developed the Lausanne medical site for Hirslanden. The Executive Committee warmly welcomes Cédric Bossart in his new role as Head of Radiology Development at the Group's headquarters and thanks Jean-Claude Chatelain for his further valuable commitment to the West Region", says Stéphan Studer, Chief Operating Officer West Region of the Hirslanden Group.

Harness synergies through joint management

Through the joint management of both Lausanne hospitals in the future, Hirslanden is strengthening the regional network concept in order to better harness the synergies between the two hospitals and to further develop the Lausanne site in a targeted manner.

Inka Moritz (51) will take over the management of both hospitals from 1 September 2021. Since the end of 2017, Inka Moritz has been Director General of the University of Health in Lausanne, where around 1200 students are currently being trained in nursing, physiotherapy, medical-technical radiology or as midwives. Before that, she worked at the University Hospital Lausanne (CHUV) for ten years. From 2012 to 2017, as Company Secretariat of the CHUV, she was responsible for political issues and communication with the health department, but also for maintaining relationships with university institutions, business associations and other hospitals. Before that, she worked at the CHUV for two years as the administrative director of the Department of Clinical Neuroscience and four years for the Department of Musculoskeletal Medicine. Before joining the CHUV, she was the Hospital Manager of the Hôpital Orthopédique de la Suisse Romande and, in this role, assisted with its merger with the CHUV. Previously, she was Deputy Company Secretariat of the Vaudois Medical Association for four years.

Inka Moritz holds a Masters in Political Science and a Master of Advanced Studies in Health Economics and Management from the University of Lausanne. She also completed the "European Health Leadership Program" at the INSEAD Institute in Fontainebleau / Paris. She also has a degree in physiotherapy and has practised this profession for several years.

"We are very pleased that, with Inka Moritz, Hirslanden has been able to gain a proven expert in the health and hospital sectors," says Stéphan Studer. He continues: "Inka Moritz is well connected in the canton of Vaud and, thanks to her many years of experience as Hospital Manager, is the ideal choice for the careful development of our two Lausanne hospitals, Bois-Cerf and Cecil. Under her overall responsibility, we will offer the population of the canton of Vaud a wide range of outpatient and inpatient services that are even more closely coordinated."

About Hirslanden

The Hirslanden Group operates 17 hospitals in 10 cantons, many of which have an emergency department. It also operates 4 outpatient surgical units, 17 radiology institutes and 5 radiotherapy institutes. Together with public and private cooperation partners, Hirslanden focuses on the continuum of care and the promoting of high-quality, responsible, personalised and efficiently integrated healthcare. The Group has 2 506 affiliated doctors and 10 417 employees, 498 of whom are permanently employed doctors. Hirslanden is the largest medical network in Switzerland. In the 2019/20 financial year, the Group generated turnover of CHF 1’804 million. As at 31.3.2020, the Group had treated 107’491 patients, amounting to a total of 471’717 inpatient days. In insurance terms, the patient mix consists of 49.2% basic, 29.3% semi-private, and 21.5% private insured patients.

Hirslanden is synonymous with first-class medical care provided by highly qualified medical specialists with many years of experience. As a system provider, the Group stands out from the rest of the market: interdisciplinary medical centres of expertise and specialised institutes enable it to offer the best possible individualised treatment, even in highly complex cases. The Hirslanden Group was formed in 1990 through the merger of several hospitals. Since 2007, it has been part of the international hospital group Mediclinic International plc, which is listed on the London Stock Exchange.